Literature DB >> 25953847

Prevalence and determinants of undiagnosed diabetic retinopathy and vision-threatening retinopathy in a multiethnic Asian cohort: the Singapore Epidemiology of Eye Diseases (SEED) study.

Olivia S Huang1, Wan Ting Tay1, Peng Guan Ong1, Charumathi Sabanayagam1, Ching-Yu Cheng1, Gavin S Tan1, Gemmy C M Cheung1, Ecosse L Lamoureux2, Tien Y Wong3.   

Abstract

OBJECTIVE: To determine the prevalence and risk factors of undiagnosed diabetic retinopathy (DR), in particular vision-threatening DR (VTDR) in a multiethnic Asian cohort.
DESIGN: A population-based survey of 3353 Chinese, 3280 Malays and 3400 Indians (73.6% response) aged 40-80 years residing in Singapore. Diabetes mellitus (DM) was defined as random glucose ≥11.1 mmol/L, use of diabetic medication or a previous physician diagnosis. DR severity was graded from retinal photographs following the modified Airlie House classification. VTDR was defined as the presence of severe non-proliferative DR (NPDR), proliferative DR (PDR) or clinically significant macular oedema (CSMO), using the Eye Diseases Prevalence Research Group definition. Participants were deemed 'undiagnosed' if they reported no prior physician diagnosis in structured interviews, in those with the condition.
RESULTS: Of 10 033 participants, 2376 had DM (23.7%), of which 805 (33.9%) had DR. Among 2376 with DM, 11.1% (n=263) were undiagnosed. Among 805 with DR, 671 (83.3%) were undiagnosed. Among 212 with VTDR, 59 (27.3%) were undiagnosed. In multivariate models, factors associated with undiagnosed VTDR were higher low-density lipoprotein (LDL) cholesterol (OR=1.53, 95% CI 0.99 to 2.35, p=0.05) and absence of visual impairment or blindness in any eye in terms of best-corrected vision OR=3.00, 95% CI 1.47 to 6.11, p=0.003).
CONCLUSIONS: In this community, a quarter with VTDR is undiagnosed, and 8 in 10 with any DR are undiagnosed, compared with only 1 in 10 with DM undiagnosed. These findings suggest that screening for diabetes is successful, while screening for DR is currently inadequate in our population. Public health strategies to aid early diagnosis of DR in Singapore are urgently warranted to reduce blindness due to diabetes. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  Epidemiology; Public health; Retina

Mesh:

Substances:

Year:  2015        PMID: 25953847     DOI: 10.1136/bjophthalmol-2014-306492

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  22 in total

Review 1.  Prevalence of Diabetic Retinopathy and Vision Loss in the Beijing Eye Study: the Potential Role of the Cerebrospinal Fluid Pressure.

Authors:  Jost B Jonas; Liang Xu; Jie Xu; Wen Bin Wei; Ya Xing Wang
Journal:  Curr Diab Rep       Date:  2015-10       Impact factor: 4.810

2.  Technical and imaging factors influencing performance of deep learning systems for diabetic retinopathy.

Authors:  Michelle Y T Yip; Gilbert Lim; Zhan Wei Lim; Quang D Nguyen; Crystal C Y Chong; Marco Yu; Valentina Bellemo; Yuchen Xie; Xin Qi Lee; Haslina Hamzah; Jinyi Ho; Tien-En Tan; Charumathi Sabanayagam; Andrzej Grzybowski; Gavin S W Tan; Wynne Hsu; Mong Li Lee; Tien Yin Wong; Daniel S W Ting
Journal:  NPJ Digit Med       Date:  2020-03-23

3.  Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes.

Authors:  Daniel Shu Wei Ting; Carol Yim-Lui Cheung; Gilbert Lim; Gavin Siew Wei Tan; Nguyen D Quang; Alfred Gan; Haslina Hamzah; Renata Garcia-Franco; Ian Yew San Yeo; Shu Yen Lee; Edmund Yick Mun Wong; Charumathi Sabanayagam; Mani Baskaran; Farah Ibrahim; Ngiap Chuan Tan; Eric A Finkelstein; Ecosse L Lamoureux; Ian Y Wong; Neil M Bressler; Sobha Sivaprasad; Rohit Varma; Jost B Jonas; Ming Guang He; Ching-Yu Cheng; Gemmy Chui Ming Cheung; Tin Aung; Wynne Hsu; Mong Li Lee; Tien Yin Wong
Journal:  JAMA       Date:  2017-12-12       Impact factor: 56.272

Review 4.  Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group.

Authors:  Winfried M Amoaku; Faruque Ghanchi; Clare Bailey; Sanjiv Banerjee; Somnath Banerjee; Louise Downey; Richard Gale; Robin Hamilton; Kamlesh Khunti; Esther Posner; Fahd Quhill; Stephen Robinson; Roopa Setty; Dawn Sim; Deepali Varma; Hemal Mehta
Journal:  Eye (Lond)       Date:  2020-06       Impact factor: 3.775

5.  Direct medical cost associated with diabetic retinopathy severity in type 2 diabetes in Singapore.

Authors:  Xiao Zhang; Serena Low; Neelam Kumari; Jiexun Wang; Keven Ang; Darren Yeo; Chee Chew Yip; Subramaniam Tavintharan; Chee Fang Sum; Su Chi Lim
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

6.  Discordance in the diagnosis of diabetes: Comparison between HbA1c and fasting plasma glucose.

Authors:  Lan T Ho-Pham; Uyen D T Nguyen; Truong X Tran; Tuan V Nguyen
Journal:  PLoS One       Date:  2017-08-17       Impact factor: 3.240

7.  Prevalence, Risk Factors, and Impact of Undiagnosed Visually Significant Cataract: The Singapore Epidemiology of Eye Diseases Study.

Authors:  Jacqueline Chua; Blanche Lim; Eva K Fenwick; Alfred Tau Liang Gan; Ava Grace Tan; Ecosse Lamoureux; Paul Mitchell; Jie Jin Wang; Tien Yin Wong; Ching-Yu Cheng
Journal:  PLoS One       Date:  2017-01-27       Impact factor: 3.240

8.  Prevalence of diabetic retinopathy in India: The All India Ophthalmological Society Diabetic Retinopathy Eye Screening Study 2014.

Authors:  Salil S Gadkari; Quresh B Maskati; Barun Kumar Nayak
Journal:  Indian J Ophthalmol       Date:  2016-01       Impact factor: 1.848

Review 9.  Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss.

Authors:  Ryan Lee; Tien Y Wong; Charumathi Sabanayagam
Journal:  Eye Vis (Lond)       Date:  2015-09-30

10.  Awareness and practices regarding eye diseases among patients with diabetes: a cross sectional analysis of the CoDiab-VD cohort.

Authors:  Lazaros Konstantinidis; Tania Carron; Eva de Ancos; Léonie Chinet; Isabelle Hagon-Traub; Emilie Zuercher; Isabelle Peytremann-Bridevaux
Journal:  BMC Endocr Disord       Date:  2017-09-07       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.